How is pre‑eclampsia diagnosed in a pregnant patient beyond 20 weeks gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Diagnose Pre-eclampsia

Pre-eclampsia is diagnosed after 20 weeks of gestation by the presence of new-onset hypertension (≥140/90 mmHg confirmed on two occasions at least 15 minutes apart) combined with either proteinuria (≥300 mg/24h or ≥+ on dipstick on more than one occasion) OR evidence of maternal organ dysfunction in the absence of proteinuria. 1

Core Diagnostic Requirements

Timing and Blood Pressure Criteria

  • Pre-eclampsia cannot be diagnosed before 20 weeks of gestation (except in rare cases such as molar pregnancy or fetal triploidy) 2, 1
  • New-onset hypertension must be documented: systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg 1
  • Blood pressure elevation must be confirmed on two separate occasions at least 15 minutes apart 1
  • The patient must have been previously normotensive, with documented normal BP before 20 weeks or in early pregnancy 2, 1

Primary Diagnostic Pathway: Hypertension + Proteinuria

  • Proteinuria is defined as ≥300 mg in a 24-hour urine collection 1
  • Alternatively, proteinuria can be detected as ≥+ on dipstick on more than one occasion 3, 2
  • This traditional combination of hypertension plus proteinuria remains the most straightforward diagnostic approach 1

Alternative Diagnostic Pathway: Hypertension + Organ Dysfunction (When Proteinuria is Absent)

When proteinuria is not present, pre-eclampsia can still be diagnosed if gestational hypertension is accompanied by ANY ONE of the following maternal organ dysfunctions 1:

Renal dysfunction:

  • Serum creatinine ≥1.1 mg/dL or doubling of baseline creatinine 1

Hepatic dysfunction:

  • Liver transaminases ≥2× upper limit of normal 2
  • Severe persistent right upper quadrant or epigastric pain 2

Hematological dysfunction:

  • Platelet count <100,000/µL 2
  • Progressive thrombocytopenia 1

Neurological complications:

  • New cerebral or visual symptoms (persistent severe headache, visual disturbances such as blurred vision, scotomata, photophobia) 2, 1
  • Hyperreflexia and clonus 4

Pulmonary complications:

  • Pulmonary edema 1

Uteroplacental dysfunction:

  • Reduced fetal movements reported by the patient 3, 2
  • Small-for-gestational-age infant on ultrasound 3, 2
  • Non-reassuring fetal status 1

Clinical Assessment Protocol After 20 Weeks

At every antenatal assessment after 20 weeks, actively screen for the following signs and symptoms 3:

  • New hypertension (measure BP at every visit) 3
  • New proteinuria (dipstick urinalysis at every visit) 3
  • Headache or visual disturbance (persistent, severe headache unresponsive to usual treatment; blurred vision, scotomata, photophobia) 3, 2
  • Epigastric pain or vomiting (severe or persistent right upper quadrant/epigastric pain; new-onset vomiting after 20 weeks) 3, 2
  • Reduced fetal movements 3, 2
  • Small-for-gestational-age infant 3

Laboratory Evaluation When Pre-eclampsia is Suspected

When clinical suspicion arises, obtain the following tests 1:

  • Complete blood count (to assess platelet count and hemolysis)
  • Liver enzymes (AST, ALT)
  • Serum creatinine and electrolytes
  • Uric acid
  • Urinalysis with protein quantification (24-hour urine collection or protein-to-creatinine ratio)

The sFlt-1/PlGF ratio ≤38 can exclude development of pre-eclampsia in the following week when clinically suspected 1, which is particularly useful in ambiguous cases.

Severity Classification: Pre-eclampsia with Severe Features

Pre-eclampsia with severe features is diagnosed when ANY of the following are present 2, 1:

  • Severe hypertension: BP ≥160/110 mmHg 2
  • Severe persistent right upper quadrant or epigastric pain 2
  • Serum creatinine >1.1 mg/dL or doubling of baseline 2
  • Platelet count <100,000/µL 2
  • Liver transaminases ≥2× upper limit of normal 2
  • New cerebral or visual symptoms unresponsive to treatment 2
  • Pulmonary edema 1
  • Non-reassuring fetal status 1

Critical pitfall: Proteinuria does NOT define the severity of preeclampsia—even a single severe feature mandates management as severe disease regardless of proteinuria level 2

Referral Thresholds Based on Findings

Diastolic BP ≥90 and <100 mmHg without proteinuria:

  • Refer for hospital assessment within 48 hours 1

Diastolic BP ≥90 and <100 mmHg with proteinuria ≥+ on dipstick:

  • Refer for same-day hospital assessment 1

Any severe feature present:

  • Immediate referral and management as severe pre-eclampsia 2, 1

Important Clinical Pitfalls

  • Transient gestational hypertension (BP elevations that resolve on repeat measurement) carries approximately 40% risk of progressing to true gestational hypertension or pre-eclampsia, requiring close follow-up with home BP monitoring 2
  • HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) represents the severe end of the pre-eclampsia spectrum and requires immediate delivery consideration 2
  • Atypical presentations can occur before 20 weeks (with molar pregnancy) or beyond 48 hours postpartum, requiring heightened clinical suspicion 5, 6
  • Eclampsia can still occur postpartum, so continued vigilance is necessary even after delivery 4

Postpartum Pre-eclampsia

Pre-eclampsia can be diagnosed postpartum as new-onset hypertension (≥140/90 mmHg) occurring 48 hours to 6 weeks after delivery with either proteinuria or maternal organ dysfunction 1. Blood pressure should be monitored at least every 4 hours while awake for at least 3 days postpartum 1, 4.

References

Guideline

Diagnosis and Management of Pre-eclampsia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Differentiating Pregnancy-Induced Hypertension and Preeclampsia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Preeclampsia Resolution and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and management of atypical preeclampsia-eclampsia.

American journal of obstetrics and gynecology, 2009

Research

Preeclampsia: Diagnosis and management of the atypical presentation.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2006

Related Questions

Can preeclampsia occur before 20 weeks of gestation?
How do preeclampsia and eclampsia differ?
Can a pregnant woman with seizures but without hypertension or proteinuria have eclampsia?
What are the diagnosis criteria for pre-eclampsia in a pregnant woman?
Can pre-eclampsia occur without hypertension?
In a 26‑year‑old male who was recently treated for pneumonia with paracetamol, cefuroxime, N‑acetylcysteine, levocetirizine and montelukast, and now has persistent tachypnea, posterior ronchi and a dry cough, what is the most likely diagnosis and what immediate investigations and management steps are required before granting fit‑to‑work clearance?
How should silent (asymptomatic) aortic stenosis be managed in an older adult patient?
What vitamin D supplementation regimen should be used for individuals at risk of deficiency such as limited sun exposure, darker skin, elderly, malabsorption disorders, medications affecting vitamin D metabolism, osteoporosis, or chronic kidney disease stage 4‑5?
How should a pregnant woman with valvular heart disease be managed, considering the type and severity of the valve lesion, New York Heart Association functional class, gestational age, and whether she has a mechanical or bioprosthetic valve?
What hormonal investigations are indicated for a reproductive‑age woman with suspected polycystic ovary syndrome (PCOS)?
How should I manage a clinically stable adult patient with afebrile neutropenia (absolute neutrophil count <500 cells/µL) who has no mucosal breakdown, no recent chemotherapy within 7 days, and no other high‑risk features?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.